This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. It is particularly significant in the development of compounds targeting the central nervous system, where its structural features contribute to enhanced binding affinity and selectivity towards specific receptors. Additionally, it plays a role in the creation of potential therapeutic agents for neurological disorders, such as anxiety, depression, and cognitive impairments. Its trifluoromethyl group enhances metabolic stability and bioavailability, making it valuable in drug design and optimization processes.